Pulmatrix (PULM) Treasury Shares (2013 - 2017)
Pulmatrix (PULM) posted Treasury Shares of $5187.0 for Q1 2017, little changed sequentially from $5187.0 in Q4 2016, and down 91.36% YoY from $60028.0 in Q1 2016.
Pulmatrix (PULM) Treasury Shares (2013 - 2017) Analysis & Trends
Pulmatrix has reported Treasury Shares for 5 years, with the latest figure at $5187.0 in Q1 2017.
- Quarterly Treasury Shares fell 91.36% year-over-year to $5187.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $5187.0 (down 91.36% YoY) and the FY2016 annual result came in at $5187.0, down 95.27% from the prior year.
- Treasury Shares steadied at $5187.0 in Q1 2017 per PULM's latest filing, from $5187.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.3 million in Q4 2013 and troughed at $5187.0 in Q2 2016.
- A 5-year average of $259995.8 and a median of $159336.0 in 2015 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2015 and 2016: Treasury Shares tumbled 51.48% in 2015, then tumbled 97.39% in 2016.
- Over 5 years, Treasury Shares stood at $1.3 million in 2013, then tumbled by 68.64% to $410000.0 in 2014, then plunged by 73.25% to $109682.0 in 2015, then slumped by 95.27% to $5187.0 in 2016, then changed by 0.0% to $5187.0 in 2017.
- According to Business Quant data, Treasury Shares over the past three periods registered $5187.0, $5187.0, and $5187.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 5,187.00 |
| Mar 31, 2017 | 5,187.00 |
| Dec 31, 2016 | 5,187.00 |
| Dec 31, 2016 | 5,187.00 |
| Sep 30, 2016 | 5,187.00 |
| Sep 30, 2016 | 5,187.00 |
| Jun 30, 2016 | 5,187.00 |
| Jun 30, 2016 | 5,187.00 |
| Mar 31, 2016 | 60,028.00 |
| Mar 31, 2016 | 60,028.00 |
| Dec 31, 2015 | 109,682.00 |
| Dec 31, 2015 | 109,682.00 |
| Sep 30, 2015 | 159,336.00 |
| Sep 30, 2015 | 159,336.00 |
| Jun 30, 2015 | 198,617.00 |
| Jun 30, 2015 | 198,617.00 |
| Mar 31, 2015 | 324,047.00 |
| Mar 31, 2015 | 324,047.00 |
| Dec 31, 2014 | 410,000.00 |
| Dec 31, 2014 | 410,000.00 |